Drug Profile
Tax 1011
Alternative Names: SBT 1011Latest Information Update: 22 Aug 2007
Price :
$50
*
At a glance
- Originator Indena
- Class Cytostatics; Taxanes
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 15 Jul 1998 No-Development-Reported for Cancer in Italy (Unknown route)
- 15 Jul 1998 No-Development-Reported for Cancer in USA (Unknown route)
- 01 Sep 1995 Preclinical development for Cancer in Italy (Unknown route)